A2B Adenosine Receptor and Cancer
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0810, USA
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(20), 5139; https://doi.org/10.3390/ijms20205139
Received: 25 September 2019
/
Revised: 11 October 2019
/
Accepted: 12 October 2019
/
Published: 17 October 2019
(This article belongs to the Special Issue G Protein-Coupled Adenosine Receptors: Molecular Aspects and Beyond)
There are four subtypes of adenosine receptors (ARs), named A1, A2A, A2B and A3, all of which are G protein-coupled receptors (GPCRs). Locally produced adenosine is a suppressant in anti-tumor immune surveillance. The A2BAR, coupled to both Gαs and Gαi G proteins, is one of the several GPCRs that are expressed in a significantly higher level in certain cancer tissues, in comparison to adjacent normal tissues. There is growing evidence that the A2BAR plays an important role in tumor cell proliferation, angiogenesis, metastasis, and immune suppression. Thus, A2BAR antagonists are novel, potentially attractive anticancer agents. Several antagonists targeting A2BAR are currently in clinical trials for various types of cancers. In this review, we first describe the signaling, agonists, and antagonists of the A2BAR. We further discuss the role of the A2BAR in the progression of various cancers, and the rationale of using A2BAR antagonists in cancer therapy.
View Full-Text
Keywords:
adenosine receptor; immune system; cancer therapy; tumor microenvironment; cell proliferation; metastasis
▼
Show Figures
Graphical abstract
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Gao, Z.-G.; Jacobson, K.A. A2B Adenosine Receptor and Cancer. Int. J. Mol. Sci. 2019, 20, 5139. https://doi.org/10.3390/ijms20205139
AMA Style
Gao Z-G, Jacobson KA. A2B Adenosine Receptor and Cancer. International Journal of Molecular Sciences. 2019; 20(20):5139. https://doi.org/10.3390/ijms20205139
Chicago/Turabian StyleGao, Zhan-Guo, and Kenneth A. Jacobson 2019. "A2B Adenosine Receptor and Cancer" International Journal of Molecular Sciences 20, no. 20: 5139. https://doi.org/10.3390/ijms20205139
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
